UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Nature medicine, 2007-09, Vol.13 (9), p.1102-1107

2007

Volltextzugriff (PDF)

Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial

PloS one, 2022-06, Vol.17 (6), p.e0263880-e0263880

2022

Volltextzugriff (PDF)

Platelet glutamate dehydrogenase activity and efficacy of antipsychotic therapy in patients with schizophrenia

Journal of medical biochemistry, 2020-01, Vol.39 (1), p.54-59

2020

Volltextzugriff (PDF)

Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study

Journal of psychiatric research, 2021-11, Vol.143, p.436-444

2021

Volltextzugriff (PDF)

The Role of Personality Functioning in Treatment Outcomes during the Long-Term Treatment with Atypical Antipsychotics in Stable Schizophrenia Patients

Acta Psychopathologica (Wilmington, Del.), 2017, Vol.3 (3)

Morozova, Margarita A

2017

Volltextzugriff (PDF)

Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial

PloS one, 2022-01, Vol.17 (6)

2022

Volltextzugriff (PDF)

Latent Dysphoria in the Structure of Emotional Disorders in Patients with Functional Constipation

Klinicheskai͡a︡ i spet͡s︡ialʹnai͡a︡ psikhologii͡a, 2021-01, Vol.10 (4), p.68-92

2021

Volltextzugriff (PDF)

A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

BMC psychiatry, 2014-12, Vol.14

2014

Volltextzugriff (PDF)

Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Nature medicine, 2007-10, Vol.13 (10), p.1264-1264

2007

Volltextzugriff (PDF)

Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Nature medicine, 2007-10, Vol.13 (10), p.1264-1264

2007

Volltextzugriff (PDF)

Platelet cytochrome c-oxidase activity in patients with acute schizophrenia in the course of their treatment with risperidone

Health (Irvine, Calif.), 2011, Vol.3 (1), p.13-19

2011

Volltextzugriff (PDF)

DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED EFFICACY AND SAFETY TRIAL OF ADD-ON TREATMENT OF DIMEBON PLUS RISPERIDONE IN SCHIZOPHRENIC PATIENTS DURING TRANSITION FROM ACUTE PSYCHOTIC EPISODE TO REMISSION

Psychiatria Danubina, 2012-06, Vol.24. (2.), p.159

2012

Volltextzugriff (PDF)

Exogenous induction of physiological ketosis in obese women (multidisciplinary, double-blind, placebo-controlled study)

Atherosclerosis, 2024-08, Vol.395

2024

Volltextzugriff (PDF)

Light-emitting diodes with Ge(Si) nanoislands embedded in photonic crystals

Nanotechnology, 2024-04, Vol.35 (16), p.165203

2024

Volltextzugriff (PDF)

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

The New England journal of medicine, 2020-05, Vol.382 (22), p.2117-2128

2020

Volltextzugriff (PDF)

Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid‐predominant mouse model of Alzheimer's disease

Journal of pharmacy and pharmacology, 2019-11, Vol.71 (11), p.1695-1705

2019

Volltextzugriff (PDF)

V. N. Vinogradov Faculty Therapy Clinic of Sechenov University: the flagship of the therapeutic service of the Russian Federation. A review

Terapevtic̆eskii arhiv, 2023-12, Vol.95 (12), p.625331

2023

Volltextzugriff (PDF)

Synthesis and activation of pH-sensitive metal-organic framework Sr(BDC) for oral drug delivery

Dalton transactions : an international journal of inorganic chemistry, 2024-01, Vol.53 (3), p.148-157

2024

Volltextzugriff (PDF)

Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in Russia

Blood, 2022-11, Vol.140 (Supplement 1), p.9654-9655

2022

Volltextzugriff (PDF)

The First Results of Asciminib Therapy in Highly Pretreated Chronic Myeloid Leukemia Patients Under the Managed Access Program (MAP) in Russian Federation

Blood, 2021-11, Vol.138 (Supplement 1), p.1483-1483

2021

Volltextzugriff (PDF)

P673: ASCIMINIB MANAGMENT IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH T315I MUTATION

HemaSphere, 2023-08, Vol.7 (S3), p.e208218c-n/a

2023

Volltextzugriff (PDF)

Autologous hematopoietic stem cell transplantation after immune checkpoint inhibitor therapy in pediatric relapsed/refractory Hodgkin lymphoma

Cellular therapy and transplantation, 2023-10, Vol.12 (3), p.17-22

2023

Volltextzugriff (PDF)

QUALITATIVE PHASE ANALYSIS OF OXIDE FILMS ON THE SURFACE OF STEEL 12Kh18N10T, FORMED AS A RESULT OF A GIVEN LASER MARKING

Metallurg, 2023 (2), p.63-69

2023

Volltextzugriff (PDF)

CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S334-S334

2023

Volltextzugriff (PDF)

POSTER: CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S175-S175

2023

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(42)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial

Platelet glutamate dehydrogenase activity and efficacy of antipsychotic therapy in patients with schizophrenia

Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study

The Role of Personality Functioning in Treatment Outcomes during the Long-Term Treatment with Atypical Antipsychotics in Stable Schizophrenia Patients

Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial

Latent Dysphoria in the Structure of Emotional Disorders in Patients with Functional Constipation

A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Platelet cytochrome c-oxidase activity in patients with acute schizophrenia in the course of their treatment with risperidone

DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED EFFICACY AND SAFETY TRIAL OF ADD-ON TREATMENT OF DIMEBON PLUS RISPERIDONE IN SCHIZOPHRENIC PATIENTS DURING TRANSITION FROM ACUTE PSYCHOTIC EPISODE TO REMISSION

Exogenous induction of physiological ketosis in obese women (multidisciplinary, double-blind, placebo-controlled study)

Light-emitting diodes with Ge(Si) nanoislands embedded in photonic crystals

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid‐predominant mouse model of Alzheimer's disease

V. N. Vinogradov Faculty Therapy Clinic of Sechenov University: the flagship of the therapeutic service of the Russian Federation. A review

Synthesis and activation of pH-sensitive metal-organic framework Sr(BDC) for oral drug delivery

Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in Russia

The First Results of Asciminib Therapy in Highly Pretreated Chronic Myeloid Leukemia Patients Under the Managed Access Program (MAP) in Russian Federation

P673: ASCIMINIB MANAGMENT IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH T315I MUTATION

Autologous hematopoietic stem cell transplantation after immune checkpoint inhibitor therapy in pediatric relapsed/refractory Hodgkin lymphoma

QUALITATIVE PHASE ANALYSIS OF OXIDE FILMS ON THE SURFACE OF STEEL 12Kh18N10T, FORMED AS A RESULT OF A GIVEN LASER MARKING

CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation

POSTER: CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation

Aktive Filter

Suchergebnisse filtern